secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2024-10-25T23:59:59+00:00
Accession:  0001493152-24-042546
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals issues 33,333 shares under ELOC and converts 200 Series B shares into 93,299 common shares
--------------------------------------------------------------------------------

- Sold 33,333 shares at $2.36 each for net proceeds of $78,787 under the $25M ELOC with Platinum Point Capital.
- Converted 200 Series B Preferred shares into 93,299 common shares at $2.358/share, value $220,000.
- Both issuances exempt from registration under Securities Act (Section 4(a)(2)/Rule 506 and Section 3(a)(9)).
- Resale of shares under ELOC and conversion are covered by effective registration statements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224042546/0001493152-24-042546-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224042546/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042546

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer